Project Grant HT94252310792
Award Date 9/30/23
Completion Date 9/29/26
Dollars Obligated $1.5M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Birmingham, AL 35294, USA
Similar Awards
- The University of Alabama at Birmingham (UAB) was awarded a $733,662 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on September 1, 2024, supports research to investigate the role of tumor glycans in immune suppression. This federally funded project aims to advance scientific understanding of how specific carbohydrate molecules on tumor cells can inhibit the body's immune response, with the goal of...
- The University of Alabama at Birmingham (UAB) was awarded a $1,485,001 Project Grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, awarded on March 1, 2025, supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The research project, titled "Overcoming Perturbations that Orchestrate Immune Exhaustion and Dysfunction in Breast Cancer,"...
- Federal Grant Award Summary The University of Alabama at Birmingham received a $650,845 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to develop macrophage-centric prognostic biomarkers for checkpoint blockade immunotherapy in melanoma. The award, which began July 1, 2025, and extends through June 30, 2028, supports advanced biomedical research aimed at identifying and validating diagnostic tools to improve...
- The University of Alabama at Birmingham (UAB) has been awarded a $297,000 Project Grant from the Department of Defense's Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. This grant, awarded on August 1, 2024, will fund research to evaluate the role of Notch signaling in chronic pancreatitis. As a leading research institution, UAB will leverage its expertise in biomedical research to advance scientific understanding and potentially improve treatment...
- Federal Project Grant Summary The University of Alabama at Birmingham received a $1,317,584 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective July 1, 2025, through June 30, 2028. This research initiative focuses on developing macrophage-centric prognostic biomarkers to improve outcomes for checkpoint blockade immunotherapy in melanoma treatment. The three-year project will advance biomedical research...
- The University of Alabama at Birmingham (UAB) has been awarded a $740,075 Project Grant from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) to conduct research on "PADI4 as a Driver and Therapeutic Target for Uveal Melanoma Therapy". The award, which runs from September 1, 2024 to August 31, 2027, will support UAB's research into novel therapeutic approaches for treating uveal melanoma, an aggressive form of eye cancer. As a leading research...
- Federal Project Grant Award Summary The University of Alabama at Birmingham received a $227,167 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period of July 1, 2025, through June 30, 2028. The research project, titled "Macrophage-Centric Prognostic Biomarkers for Checkpoint Blockade Immunotherapy in Melanoma," focuses on developing and validating diagnostic biomarkers to improve patient...
- The University of Alabama at Birmingham (UAB) received a $1,599,981.00 Project Grant award from the Defense Health Agency on June 1, 2024 under the Military Medical Research and Development program (CFDA 12.420). The grant supports research to activate immune reserves and prevent secondary bacterial lung infections after trauma and hemorrhage. This biomedical research project aims to improve health outcomes for military service members and the broader public. The project will be conducted over a...
- The University of Alabama at Birmingham (UAB) received a $724,115 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420). The purpose of this 3-year grant, awarded on September 1, 2024, is to conduct research on the utility of sodium nitrite in improving recovery after spinal cord injuries. As a leading research institution, UAB will leverage its expertise in biomedical engineering, neuroscience, and clinical trials to...
- The University of Alabama at Birmingham (UAB) was awarded a $220,326 project grant from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) to develop novel, selective PARP protein degraders for prostate cancer treatment utilizing PSMA uptake enhancement. The award period runs from April 1, 2025 to March 31, 2027. This grant supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public...